Document Detail


Nitric oxide in neonatal hypoxemic respiratory failure.
MedLine Citation:
PMID:  22372677     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Nitric oxide (NO) is a cellular signaling molecule and a powerful vasodilator. NO modulates basal pulmonary vascular tone and it is important to reduce blood pressure and to treat hypoxemic respiratory failure, such as persistent pulmonary hypertension (PPHN) in newborns. PPHN is defined as a failure of normal pulmonary vascular adaptation at or soon after birth, resulting in a persisting high pulmonary vascular resistance. iNO therapy decreases the need of extracorporeal membrane oxygenation (ECMO) although it did not reduce mortality of these patients. Severe meconial aspiration syndrome is associated with PPHN, resulting in severe hypoxemia; iNO administration combined with HFV, results in ameliorate oxygenation. The cause of hypoxemic respiratory failure in patients with congenital diaphragmatic hernia (CDH) is complex. CDH patients experienced oxygenation improvement after iNO therapy but they can be often considered iNO poor responders. In some cases iNO therapy can reduce the need of ECMO in pre-surgical stabilization. The pathophysiology of respiratory failure and the potential risks differ substantially in preterm infants. Pulmonary hypertension can complicate respiratory failure in preterm babies. Current evidence does not support use of iNO in early routine, early rescue or layer rescue regimens in the care of preterm infants.
Authors:
Mc Muraca; S Negro; B Sun; G Buonocore
Related Documents :
3693087 - Lung development in the marsupial bandicoot, isoodon macrourus.
10596707 - A simple new technique to measure the effective dead space of the face mask with a wate...
11865267 - Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic...
8021797 - Effects of morphine and pancuronium on lung volume and oxygenation in premature infants...
11471167 - Analysis of the ephx1 113 polymorphism and gstm1 homozygous null polymorphism and oral ...
10622297 - Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant-...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-28
Journal Detail:
Title:  The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians     Volume:  -     ISSN:  1476-4954     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101136916     Medline TA:  J Matern Fetal Neonatal Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Siena Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dehydrative fragmentation of 5-hydroxyalkyl-1H-tetrazoles: a mild route to alkylidenecarbenes.
Next Document:  Reference values for airway resistance (Rint) in newborns, infants and pre-schoolers from a Latin Am...